National Cancer Institute; Notice of Meeting, 4487 [2019-02470]

Download as PDF Federal Register / Vol. 84, No. 32 / Friday, February 15, 2019 / Notices khammond on DSKBBV9HB2PROD with NOTICES The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will also be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov/). Name of Committee: National Cancer Institute Clinical Trials and Translational Research Advisory Committee. Date: July 17, 2019. Time: 8:00 a.m. to 4:00 p.m. Agenda: Strategic Discussion of NCI’s Clinical and Translational Research Programs. Place: National Cancer Institute Shady Grove, East Wing, Seminar Room 110, 9609 Medical Center Drive, Rockville, MD 20850. Contact Person: Sheila A. Prindiville, MD, MPH Director, Coordinating Center for Clinical Trials, National Institutes of Health, National Cancer Institute, Coordinating Center for Clinical Trials, 9609 Medical Center Drive, Room 6W136, Rockville, MD 20850, 240–276–6173 prindivs@mail.nih.gov. Name of Committee: National Cancer Institute Clinical Trials and Translational Research Advisory Committee. Date: November 6, 2019. Time: 8:00 a.m. to 4:00 p.m. Agenda: Strategic Discussion of NCI’s Clinical and Translational Research Programs. Place: National Cancer Institute Shady Grove, East Wing, Conference, Room TE406, 9609 Medical Center Drive, Rockville, MD 20850. Contact Person: Sheila A. Prindiville, MD, MPH, Director, Coordinating Center for Clinical Trials, National Institutes of Health, National Cancer Institute, Coordinating Center for Clinical Trials, 9609 Medical Center Drive, Room 6W136, Rockville, MD 20850, 240–276–6173, prindivs@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NCI Shady Grove has instituted stringent procedures for entrance into the NCI Shady Grove building. Visitors will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and VerDate Sep<11>2014 19:41 Feb 14, 2019 Jkt 247001 Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 11, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–02472 Filed 2–14–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Institute Council of Research Advocates. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov). Name of Committee: National Cancer Institute Council of Research Advocates. Date: April 11, 2019. Time: 9:30 a.m. to 4:00 p.m. Agenda: Welcome and Chairman’s Remarks, NCI Updates, Legislative Update, Budget Update, and Director’s Update. Place: National Institutes of Health, 31 Center Drive, Building 31, 11A01, Bethesda, MD 20892. Contact Person: Amy Williams, NCI Office of Advocacy Relations, National Cancer Institute, NIH, 31 Center Drive Building 31, Room 10A28, Bethesda, MD 20892, 240–781– 3360, williaam@mail.nih.gov. Name of Committee: National Cancer Institute Council of Research Advocates. Date: June 05, 2019. Time: 9:30 a.m. to 4:00 p.m. Agenda: Welcome and Chairman’s Remarks, NCI Updates, Legislative Update, Budget Update, and Director’s Update. Place: National Institutes of Health 31 Center Drive, Building 31, 11A01, Bethesda, MD 20892. Contact Person: Amy Williams, NCI Office of Advocacy Relations, National Cancer Institute, NIH, 31 Center Drive Building 31, Room 10A28, Bethesda, MD 20892, 240–781– 3360, williaam@mail.nih.gov. Name of Committee: National Cancer Institute Council of Research Advocates. Date: September 09, 2019. PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 4487 Time: 9:30 a.m. to 4:00 p.m. Agenda: Welcome and Chairman’s Remarks, NCI Updates, Legislative Update, Budget Update, and Director’s Update. Place: National Institutes of Health, 31 Center Drive, Building 31, 11A01, Bethesda, MD 20892. Contact Person: Amy Williams, NCI Office of Advocacy Relations, National Cancer Institute, NIH, 31 Center Drive, Building 31, Room 10A28, Bethesda, MD 20892, 240–781– 3360, williaam@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: NCRA: https://deainfo.nci.nih.gov/advisory/ ncra/ncra.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: February 11, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2019–02470 Filed 2–14–19; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. E:\FR\FM\15FEN1.SGM 15FEN1

Agencies

[Federal Register Volume 84, Number 32 (Friday, February 15, 2019)]
[Notices]
[Page 4487]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02470]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Cancer 
Institute Council of Research Advocates.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting. The open session will be videocast and can be 
accessed from the NIH Videocasting and Podcasting website (https://videocast.nih.gov).

    Name of Committee: National Cancer Institute Council of Research 
Advocates.
    Date: April 11, 2019.
    Time: 9:30 a.m. to 4:00 p.m.
    Agenda: Welcome and Chairman's Remarks, NCI Updates, Legislative 
Update, Budget Update, and Director's Update.
    Place: National Institutes of Health, 31 Center Drive, Building 
31, 11A01, Bethesda, MD 20892.
    Contact Person: Amy Williams, NCI Office of Advocacy Relations, 
National Cancer Institute, NIH, 31 Center Drive Building 31, Room 
10A28, Bethesda, MD 20892, 240-781-3360, williaam@mail.nih.gov.

    Name of Committee: National Cancer Institute Council of Research 
Advocates.
    Date: June 05, 2019.
    Time: 9:30 a.m. to 4:00 p.m.
    Agenda: Welcome and Chairman's Remarks, NCI Updates, Legislative 
Update, Budget Update, and Director's Update.
    Place: National Institutes of Health 31 Center Drive, Building 
31, 11A01, Bethesda, MD 20892.
    Contact Person: Amy Williams, NCI Office of Advocacy Relations, 
National Cancer Institute, NIH, 31 Center Drive Building 31, Room 
10A28, Bethesda, MD 20892, 240-781-3360, williaam@mail.nih.gov.

    Name of Committee: National Cancer Institute Council of Research 
Advocates.
    Date: September 09, 2019.
    Time: 9:30 a.m. to 4:00 p.m.
    Agenda: Welcome and Chairman's Remarks, NCI Updates, Legislative 
Update, Budget Update, and Director's Update.
    Place: National Institutes of Health, 31 Center Drive, Building 
31, 11A01, Bethesda, MD 20892.
    Contact Person: Amy Williams, NCI Office of Advocacy Relations, 
National Cancer Institute, NIH, 31 Center Drive, Building 31, Room 
10A28, Bethesda, MD 20892, 240-781-3360, williaam@mail.nih.gov.

    Any interested person may file written comments with the committee 
by forwarding the statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one form 
of identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.
    Information is also available on the Institute's/Center's home 
page: NCRA: https://deainfo.nci.nih.gov/advisory/ncra/ncra.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer 
Construction; 93.393, Cancer Cause and Prevention Research; 93.394, 
Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment 
Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers 
Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, 
National Institutes of Health, HHS)

    Dated: February 11, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-02470 Filed 2-14-19; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.